¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta

* = Required fields

Enter your email address

User name *

Annals of Hepatology

Buscar en

Annals of Hepatology

Toda la web

Inicio Annals of Hepatology Articles in press

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Web of Science, Medline/PubMed, DOAJ and Conacyt

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more

Impact factor 2023

3.7

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2023

7.9

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2023

0.289

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2023

0.941

View more metrics

Journal Information

Articles in press

Articles in press are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info

An exploratory machine learning model for predicting advanced liver fibrosis in autoimmune hepatitis patients: A preliminary study

Qinglin Wei, Wen Li, Shubei He, Hongbo Wu, Qiaoling Xie, Ying Peng, Xingyue Zhang

10.1016/j.aohep.2024.101754

Full text access

Uncorrected Proof. Available online 18 December 2024

Effect of bariatric endoscopy on liver fibrosis and steatosis and the course of NAFLD – a prospective interventional study

Adam Vašura, Evžen Machytka, Ondřej Urban, Jitka Macháčková, Lubomír Pavliska, Zdeněk Berka, Zdeněk Švagera, Marek Bužga

10.1016/j.aohep.2024.101765

Full text access

Uncorrected Proof. Available online 18 December 2024

Mechanisms and therapeutic targets of mitochondria in the progression of metabolic dysfunction-associated steatotic liver disease

Chenyang Mu, Sijie Wang, Zenghan Wang, Jian Tan, Haozan Yin, Yuefan Wang, Zhihui Dai, Dongyang Ding, Fu Yang

10.1016/j.aohep.2024.101774

Full text access

Pre-proof. Available online 18 December 2024

The role of inflammasomes in hepatocellular carcinoma: Mechanisms and therapeutic insights

Valentina Arrè, Roberto Negro, Gianluigi Giannelli

10.1016/j.aohep.2024.101772

Full text access

Pre-proof. Available online 18 December 2024

Tumor-associated macrophages contribute to cholangiocarcinoma progression and chemoresistance through activation of ID1

Yinghao Guo, Shuangda Miao, Yun Jin, Qi Li, Yihang Wang, Xiaoxiao Zhang, Jiangtao Li

10.1016/j.aohep.2024.101773

Full text access

Uncorrected Proof. Available online 18 December 2024

Diagnostic performance of FibroTouch® in assessing hepatic steatosis and fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: An Asian experience

Thanikan Sukaram, Soe Thiha Maung, Yuda Chongpison, Tassanan Jaihan, Chonlada Phathong, Roongruedee Chaiteerakij

10.1016/j.aohep.2024.101753

Full text access

Uncorrected Proof. Available online 16 December 2024

Lipocalin-2 silencing alleviates sepsis-induced liver injury through inhibition of ferroptosis

Yuping Li, Lu Li, Yuming Zhang, Qi Yun, Ruoli Du, Hongwei Ye, Zhenghong Li, Qin Gao

10.1016/j.aohep.2024.101756

Full text access

Uncorrected Proof. Available online 16 December 2024

Rifaximin treatment in patients with severe alcoholic hepatitis: A multicenter, randomized controlled, open-label, pilot trial

Do Seon Song, Jin Mo Yang, Young Kul Jung, Hyung Joon Yim, Hee Yeon Kim, Chang Wook Kim, Soon Sun Kim, Jae Youn Cheong, ... Young Seok Kim

10.1016/j.aohep.2024.101749

Full text access

Uncorrected Proof. Available online 16 December 2024

PNPLA3 and SAMM50 variants are associated with lean nonalcoholic fatty liver disease in Asian population

Chia-Wen Lu, Tzu-Jung Chou, Tsan-Yu Wu, Yi-Hsuan Lee, Hung-Jen Yang, Kuo-Chin Huang

10.1016/j.aohep.2024.101761

Full text access

Uncorrected Proof. Available online 13 December 2024

Racial and ethnic disparities in alcohol-associated liver disease hospitalizations in Brazil before and after the COVID-19 pandemic

Daniel L Heringer, Gabriel P.A. Costa, Jeremy Weleff, Victor Rodrigues, Shreya Sengupta, Akhil Anand

10.1016/j.aohep.2024.101742

Full text access

Uncorrected Proof. Available online 13 December 2024